RecruitingNot Applicable

Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes

Germany12,000 participantsStarted 2021-02-18

Plain-language summary

For the retrospective data analysis, patients with genetic diseases of any age and, if available, other family members, for whom genetic analyzes were carried out between 10/2016 and 12/2020, should be included. This equates to approximately 13,000 records, minus combined analyzes in the same patient, an estimated 12,000 individuals.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with genetic disease or * Family members * Genetic analysis between 10/2016 and 12/2020 at the Institute for Medical Genetics and Applied Genomics at the University Hospital Tübingen Exclusion Criteria: \- None

What they're measuring

Diagnosis

Timeframe: Day 1

Trial details

NCT IDNCT04731857

SponsorUniversity Hospital Tuebingen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-02

Contact for this trial

Tobias Haack, Dr.

+49 7071 298 tobias.haack@med.uni-tuebingen.de

View on ClinicalTrials.gov More Rare Diseases trials